Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Metastatic Breast Cancer|Hormone Receptor-positive Breast Cancer|HER2-negative Breast Cancer
Interventions: DRUG: Fulvestrant|DRUG: Anastrozole|DRUG: Abemaciclib
Sponsor: University of California, Irvine